1Hackman K D, Weiner G J, Daves C S, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia:10 000/μ L versus 20 000/μL[J]. J Clin Onco1,1997,15:1143-1149.
2Wandt H, Frank M, Ehninger G, et al.Safety and cost effectiveness of a 1010/trigger for prophylactic platelet transfusions compared with the traditional 2010/trigger:a rpspective comarative thal in 105 patients with acute myeloid leukemia[J]. Blcod,1998,9
3Zumberg M S,der Rosario M L, Nejame C F, et al. A prospective randomized trival of prophylactic platelet transfusio and bleeding incidence in hematopoietic stem cell transplant recipients:10 000/versus 20 000/trigger [J]. Biol Blood Marrow Transplant,2002
4Gaydos L A, Freireich E J, Mentel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia[J]. NEJM, 1962,266:905-909.
5Aderka D, Pratt G, Santo M, et al. Bleeding due to thrombocytopenia in acute leukemiasand reevaluation of the prophylactic platelet transfusion policy [J]. Am Jmed Sci,1986,291:147-151.
6Hanson S R, Slichter S I. Platelet kinetics in patients with bone marrow hypoplasia:evidence for a fixed platelet requirrement [J]. Blood,1985,66:1105.
7Slichter S J. Platet transfusios:a constantly evolving therapy [J]. Thromb Heamost,1991,66:178-188.
8Gmur J, Burger J, Schanz U, et al. Safety of strigent prophylactic platelet transfusion policy for patients with acute leukemia [J].Lancet, 1991,338:1223 - 1226.
9Rebulla P, Finazzi G, Marangoni F, et al.The threshold for prophylactic platelet transfusio s in adults with acute myeloid leukemia[J]. NEJM,1997,337:1870-1875.
10Benjamin R J, Anderson K C. What is the proper threshold for platelet transfusion in patients with chemotherapy- induced thrombocytopenia [J]. Critical Rev Oncol Hematol, 2002,42:163 - 171.
二级参考文献4
1Heckman KD,Weiner GJ,Davis CS,et al.Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia:10 000/μl versus 20 000/μl.J Clin Oncol,1997,15:1143-1149
2Wandt H,Frank M,Ehninger G,et al.Safety and cost effectiveness of a 10×109/L trigger for prophylactic platelet transfusions compared with the traditional 20×109/L trigger:a prospective comparative trial in 105 patients with acute myeloid leukemia.Blood,1998,91:3601-3606
3Wandt H,Frank M,Gramatzki M,et al.Safety of the 10 000/μl trigger for prophylactic platelet transfusion:prospective multicenter experience in 734 patients with acute myeloid leukemia.Blood,2000,96(suppl):3536a
4Rebulla P,Finazzi G,Marangoni F,et al.The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia.N Engl J Med,1997,337:1870-1875
6Schiffer CA,Anderson KC,Bennett CL,et al.Platelet Transfusion for Patients with Cancer:Clinical Practice Guidelines of the American Society of Clinical Oncology.J Clin Oncol,2001,19:1519-1538.
7Rebulla P,Finazzi G,Marangoni F,et al.The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia.N Engl J Med,1997,337:1870-1875.
9Strauss RG,Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions,Cur Opin Hematol,2005,12:499-502.
10Callow CR,Swindell R,Randall W,et al.The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.Br J Haematol,2002,118:677-682.
